Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 11, 2022

SELL
$126.46 - $235.05 $1,391 - $2,585
-11 Closed
0 $0
Q4 2021

Jan 26, 2022

BUY
$225.82 - $368.51 $2,484 - $4,053
11 New
11 $2,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $23.6B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Andrew Hill Investment Advisors, Inc. Portfolio

Follow Andrew Hill Investment Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Andrew Hill Investment Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Andrew Hill Investment Advisors, Inc. with notifications on news.